Kunshan Kersen Science & Technology Co.,Ltd. (SHA:603626)
China · Delayed Price · Currency is CNY 24.23
+2.20 (9.99%)
At close: Feb 6, 2026
SHA:603626 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,172 | 3,341 | 2,567 | 3,318 | 3,947 | 3,463 |
Other Revenue | 41.63 | 41.63 | 30 | 105.24 | 199.81 | 4.11 |
| 3,213 | 3,382 | 2,597 | 3,424 | 4,147 | 3,467 | |
Revenue Growth (YoY) | -2.81% | 30.26% | -24.16% | -17.44% | 19.61% | 62.98% |
Cost of Revenue | 2,972 | 3,210 | 2,286 | 2,927 | 3,405 | 2,913 |
Gross Profit | 241.15 | 172.25 | 310.13 | 496.59 | 742.11 | 554.14 |
Selling, General & Admin | 321.93 | 324.01 | 324.22 | 255.58 | 289.05 | 288.89 |
Research & Development | 258.94 | 236.82 | 183.5 | 201.61 | 234.64 | 203.36 |
Other Operating Expenses | 16.69 | 16.55 | 26.41 | 27.94 | 36.77 | 19.87 |
Operating Expenses | 592.31 | 600.05 | 528.01 | 480.14 | 572.68 | 531.56 |
Operating Income | -351.16 | -427.8 | -217.87 | 16.45 | 169.42 | 22.58 |
Interest Expense | -47.12 | -49.44 | -47.6 | -59.55 | -76.55 | -65.6 |
Interest & Investment Income | 5.86 | 8.53 | 6.76 | 15.48 | 242.49 | 6.16 |
Currency Exchange Gain (Loss) | 33.28 | 33.28 | 16.22 | 97.17 | -22.8 | -39.28 |
Other Non Operating Income (Expenses) | -6.49 | 1.11 | -1.1 | -1.93 | -1.93 | -1.59 |
EBT Excluding Unusual Items | -365.62 | -434.32 | -243.59 | 67.61 | 310.63 | -77.73 |
Gain (Loss) on Sale of Investments | 2.43 | 5.12 | -0.27 | 24.68 | 0.88 | 0.18 |
Gain (Loss) on Sale of Assets | 51.15 | -13.37 | -7.72 | -0.84 | -0.18 | -0.57 |
Asset Writedown | -15.88 | -20.57 | -49.54 | -2.3 | -0.66 | - |
Other Unusual Items | -59.02 | -57.08 | 16.6 | 18.33 | 42.74 | 14.14 |
Pretax Income | -386.95 | -520.22 | -284.53 | 107.48 | 353.42 | -63.99 |
Income Tax Expense | -29.31 | -43.39 | -3.12 | 20.71 | -16.14 | -9.46 |
Earnings From Continuing Operations | -357.64 | -476.83 | -281.41 | 86.78 | 369.56 | -54.53 |
Minority Interest in Earnings | - | - | - | - | -0.53 | 6.9 |
Net Income | -357.64 | -476.83 | -281.41 | 86.78 | 369.03 | -47.62 |
Net Income to Common | -357.64 | -476.83 | -281.41 | 86.78 | 369.03 | -47.62 |
Net Income Growth | - | - | - | -76.48% | - | - |
Shares Outstanding (Basic) | 553 | 554 | 552 | 542 | 520 | 463 |
Shares Outstanding (Diluted) | 553 | 554 | 552 | 542 | 520 | 463 |
Shares Change (YoY) | 0.85% | 0.48% | 1.74% | 4.35% | 12.19% | 12.73% |
EPS (Basic) | -0.65 | -0.86 | -0.51 | 0.16 | 0.71 | -0.10 |
EPS (Diluted) | -0.65 | -0.86 | -0.51 | 0.16 | 0.71 | -0.10 |
EPS Growth | - | - | - | -77.46% | - | - |
Free Cash Flow | -22.61 | -192.65 | 160.54 | 329.69 | -272.28 | -625.04 |
Free Cash Flow Per Share | -0.04 | -0.35 | 0.29 | 0.61 | -0.52 | -1.35 |
Dividend Per Share | - | - | 0.130 | - | - | - |
Gross Margin | 7.51% | 5.09% | 11.94% | 14.51% | 17.89% | 15.98% |
Operating Margin | -10.93% | -12.65% | -8.39% | 0.48% | 4.08% | 0.65% |
Profit Margin | -11.13% | -14.10% | -10.84% | 2.54% | 8.90% | -1.37% |
Free Cash Flow Margin | -0.70% | -5.70% | 6.18% | 9.63% | -6.57% | -18.03% |
EBITDA | -27.37 | -73.96 | 176.05 | 394.58 | 502.9 | 293.07 |
EBITDA Margin | -0.85% | -2.19% | 6.78% | 11.53% | 12.13% | 8.45% |
D&A For EBITDA | 323.79 | 353.84 | 393.92 | 378.13 | 333.47 | 270.49 |
EBIT | -351.16 | -427.8 | -217.87 | 16.45 | 169.42 | 22.58 |
EBIT Margin | -10.93% | -12.65% | -8.39% | 0.48% | 4.08% | 0.65% |
Effective Tax Rate | - | - | - | 19.26% | - | - |
Revenue as Reported | 3,213 | 3,382 | 2,597 | 3,424 | 4,147 | 3,467 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.